Disorders in the System of Mineral and Bone Metabolism Regulators—FGF-23, Klotho and Sclerostin—in Chronic Kidney Disease: Clinical Significance and Possibilities for Correction-Reference-Cited by-同舟云学术

Disorders in the System of Mineral and Bone Metabolism Regulators—FGF-23, Klotho and Sclerostin—in Chronic Kidney Disease: Clinical Significance and Possibilities for Correction

Published:2018-02-21 Issue: Volume: Page:
ISSN:
Container-title:Chronic Kidney Disease - from Pathophysiology to Clinical Improvements
language:
Short-container-title:

Author:

Milovanova Ludmila Y.,Fomin Victor V.,(Kozlovskaya) Lidia V. Lysenko,Mukhin Nikolay A.,Milovanova Svetlana Y.,Taranova Marina V.,Milovanov Yuriy S.,Kozlov Vasiliy V.,Usubalieva Aigul Zh.

Publisher

InTech

Link

http://www.intechopen.com/download/pdf/55757

Reference59 articles.

1. Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney International. 2011;80(12):1258-1270. DOI: 10.1038/ki.2011.368

2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004;351:1296-1305. DOI: 10.1056/NEJMoa041031

3. Garland JS, Holden RM, Groome PA, et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. American Journal of Kidney Disease. 2008;52(5):849-858. DOI: 10.1053/j.ajkd.2008.04.012

4. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. Journal of the American Society of Nephrology. 2001;12:1079-1084.

5. Hu MC, Shiizaki K, Kuro-o M, et al. Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Annual Review of Physiology. 2013;75:503-533. DOI: 10.1146/annurev-physiol-030212-183727

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients;International Journal of Nephrology;2021-09-23

2. Biomarkers of heart and vascular lesions in the framework of mineral and bone disorders in chronic kidney disease, correction possibilities;Clinical Medicine (Russian Journal);2021-09-20

3. Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D;Terapevticheskii arkhiv;2020-07-09

4. Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study;Terapevticheskii arkhiv;2019-06-15

5. Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease;Terapevticheskii arkhiv;2019-06-15